Among them, ITGB4, located at 17q25.1, has been reported to be aberrantly expressed in several cancers, including breast, pancreatic, lung, and gastric cancers, and may be positively associated with poor prognosis.15, 16, 17, 18, 19. Here, ITGB4 is linked to gastric cancer.